The remaining drug can be continuously released for several months
Chemotherapy Recovery Enhancement Preliminary Research Research demonstrates FOXO4-DRI's potential to accelerate recovery from chemotherapy-induced damage by eliminating senescent cells that accumulate following cytotoxic cancer treatment and contribute to long-term side effects
The rest of the tests were "fine" and I am going to get an MRI on my head and spine to check that the cervical spinal stenosis hasn't been further damaged
Evidence and user reports indicate: Short term (24 weeks): improved hydration, smoother texture, and reduced redness due to better barrier repair and moisture balance
The challenge is not whether GHK-Cu has biological activity (that is well-established) but whether that activity can be delivered to tissues at concentrations and durations sufficient to produce clinical effects beyond the skin surface
Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made